Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease Chapter 17

  • Forsythe P
  • Bienenstock J
  • Kunze W
ISSN: 0065-2598
N/ACitations
Citations of this article
837Readers
Mendeley users who have this article in their library.

Abstract

Abstract In a healthy gut, the immune system tolerates a diverse microbial commensal community avoiding inappropriate inflammation responses and mini- mizing the presence of pathogens. When the balance between host and microbes is disrupted, risk for disease increases. There is mounting evidence that microbial dysbiosis is a substantial risk factor for common gut diseases including IBS, IBD and colorectal cancer. Understanding this dysbiosis is challenging because of the extraordinary complexity of the gut ecosystem and the tremendous variability between healthy individuals in the taxa that make up the human microbiome. Advances in technology, especially sequencing technology, are beginning to allow for a full description of this complexity. In this review, we consider how new “omics” technology can be applied to the study of the gut ecosystem in human and animal models with special consideration given to factors that should be considered in the design of experiments and clinical trials.

Cite

CITATION STYLE

APA

Forsythe, P., Bienenstock, J., & Kunze, W. A. (2014). Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease Chapter 17. Advances in Experimental Medicine and Biology, 817, 115–133. Retrieved from http://link.springer.com/10.1007/978-1-4939-0897-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free